Related Experiment Videos
Periventricular hemorrhage in a developing world. Is drug intervention appropriate?
M Adhikari1, E Gouws, P K Desai
1Department of Paediatrics and Child Health, Faculty of Medicine, University of Natal, Durban, South Africa.
Brain & Development
|May 1, 1995
Summary
Low birth weight and asphyxia are key factors for periventricular hemorrhage (PVH) and mortality in vulnerable infants. Improving neonatal care is crucial before considering drug interventions for PVH prevention.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
- Public Health
Background:
- Periventricular hemorrhage (PVH) is a significant concern in low-birth-weight infants.
- Identifying risk factors is crucial for improving outcomes in disadvantaged communities.
Purpose of the Study:
- To examine factors associated with PVH development in black low-birth-weight infants.
- To assess the potential role of drug intervention for PVH prevention.
Main Methods:
- Retrospective study of 177 infants weighing less than 1.5 kg.
- Analysis of clinical data and neuroimaging (ultrasound) for PVH grading.
- Logistic regression to identify risk factors for PVH and mortality.
Main Results:
- 45.2% of infants developed PVH, with higher grades associated with increased mortality.
- Lower birth weight, asphyxia, and need for plasma were significant risk factors for mortality.
- Lower birth weight and need for plasma were crucial factors for PVH development.
Conclusions:
- Lower birth weight and asphyxia are major contributors to PVH and mortality.
- Current drug interventions for PVH may not be appropriate; focus should be on improving general neonatal care.
- Further research is needed to optimize care for high-risk infants.